712 ORAL Clinical outcome in gastrointestinal stromal tumor patients who interrupted imatinib after achieving stable disease or better response

首页> 外文期刊>European Journal of Cancer Supplements >712 ORAL Clinical outcome in gastrointestinal stromal tumor patients who interrupted imatinib after achieving stable disease or better response

【24h】

712 ORAL Clinical outcome in gastrointestinal stromal tumor patients who interrupted imatinib after achieving stable disease or better response

机译：712口服胃肠道间质瘤患者在达到稳定的疾病或改善疗效后中断伊马替尼的临床结局

获取原文

开具论文收录证明 >>

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2005年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical outcome in gastrointestinal stromal tumor patients who interrupted imatinib after achieving stable disease or better response. [J] . Lee JL, Ryu MH, Chang HM, Japanese journal of clinical oncology. . 2006,第11期

机译：胃肠道间质瘤患者在达到稳定的疾病或获得更好的反应后中断伊马替尼的临床结局。
2. Clinical Outcome in Gastrointestinal Stromal Tumor Patients who Interrupted Imatinib after Achieving Stable Disease or Better Response* [J] . Jae-Lyun Lee, Min-Hee Ryu, Heung Moon Chang, Japanese Journal of Clinical Oncology . 2006,第11期

机译：实现稳定疾病或更佳反应后中断伊马替尼的胃肠道间质瘤患者的临床结果*
3. Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib?￠????Treated Patients With Gastrointestinal Stromal Tumors [J] . LE Friberg, G Schiavon, A Ruggiero, CPT: Pharmacometrics & Systems Pharmacology . 2017,第7期

机译：伊马替尼治疗的胃肠道间质瘤患者肝转移瘤的直径，体积和密度的药理学模型及其与临床结果的关系
4. International classifications of gastrointestinal stromal tumor: a clue for adjuvant imatinib treatment [C] . Tzen Chin-Yuan International Gastric Cancer Congress . 2011

机译：胃肠道间质瘤的国际分类：佐剂伊马替尼治疗的线索
5. Molecular mechanisms of response in gastrointestinal stromal tumors treated with imatinib mesylate [D] . McAuliffe, John Christopher 2007

机译：甲磺酸伊马替尼治疗胃肠道间质瘤的分子机制
6. Pharmacometric Modeling of Liver Metastases Diameter Volume and Density and Their Relation to Clinical Outcome in Imatinib‐Treated Patients With Gastrointestinal Stromal Tumors [O] . E Schindler, SM Krishnan, RHJ Mathijssen, 2017

机译：伊马替尼治疗的胃肠道间质瘤患者肝转移瘤的直径体积和密度的药理学模型及其与临床结果的关系
7. Clinical Outcome in Gastrointestinal Stromal Tumor Patients who Interrupted Imatinib after Achieving Stable Disease or Better Response* [O] . Jae-lyun Lee, Min-hee Ryu, Heung Moon Chang, 2006

机译：胃肠道间质瘤患者在达到稳定的疾病或更好的反应后中断伊马替尼的临床结果*

712 ORAL Clinical outcome in gastrointestinal stromal tumor patients who interrupted imatinib after achieving stable disease or better response

著录项

引文网络

相似文献

相关主题

期刊订阅